IP Library Assignment 016215/0026
Patent Assignment
Reel/Frame 016215/0026

Assignment of Assignor's Interest

Recorded: 2005-05-12 Pages: 8
Assignor
TRIAD THERAPEUTICS, INC.
Executed: 2004-12-01
Assignee
NOVARTIS PHARMA AG
LICHTSTRASSE 35, 4056 BASEL/BS, SWITZERLAND
Covered Properties (5)
P-38 Inhibitors
Patent: 7,652,044 →
Application: 10/860,768 →
Publication: US 2004/0254236
5-Membered Heterocycle-Based P38 Kinase Inhibitors
Patent: 7,863,314 →
Application: 10/877,534 →
Publication: US 2005/0049288
P-38 Kinase Inhibitors
Patent: 7,700,622 →
Application: 10/898,581 →
Publication: US 2005/0020590
Bicyclic heterocyclic P-38 kinase inhibitors
Application: 60/575,113 →
Inhibitors of c-Jun N terminal kinases (JNK) and p-38 kinases
Application: 60/622,519 →
Related Assignments (10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 6, 2004
From: DONG, QING; PIERRE, FABRICE; WANG, JIANQIANG
To: TRIAD THERAPEUTICS, INC.
Reel/Frame 015055/0435 →
Assignment of Assignor's Interest Sep 1, 2004
From: FRYSZMAN, OLGA M.; LANG, HENGYUAN; LAN, JIONG; CHANG, EDCON
To: TRIAD THERAPEUTICS, INC.
Reel/Frame 015100/0016 →
Assignment of Assignor's Interest Sep 9, 2004
From: DONG, QING; WANG, JIANQIANG; LAN, JIONG; LANG, HENGYUAN
To: TRIAD THERAPEUTICS, INC.
Reel/Frame 015115/0860 →
Assignment of Assignor's Interest Feb 1, 2006
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 017225/0548 →
Assignment of Assignor's Interest Sep 30, 2015
From: NOVARTIS PHARMA AG
To: MEREO BIOPHARMA 1 LIMITED
Reel/Frame 036695/0602 →
Assignment of Assignor's Interest Nov 3, 2015
From: NOVARTIS AG
To: NOVARTIS PHARMA AG
Reel/Frame 036952/0483 →
Security Interest Aug 10, 2017
From: MEREO BIOPHARMA 1 LIMITED
To: KREOS CAPITAL V (UK) LIMITED
Reel/Frame 043523/0317 →
Change of Address May 23, 2018
From: MEREO BIOPHARMA 1 LIMITED
To: MEREO BIOPHARMA 1 LIMITED
Reel/Frame 046223/0457 →
Security Interest Nov 7, 2018
From: MEREO BIOPHARMA 1 LIMITED
To: KREOS CAPITAL V (UK) LIMITED
Reel/Frame 047446/0556 →
Release of Security Interest Jan 23, 2021
From: KREOS CAPITAL V (UK) LIMITED
To: MEREO BIOPHARMA 1 LIMINTED
Reel/Frame 055010/0654 →